Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of CL Wear Between Two Allergy Drops

This study has been withdrawn prior to enrollment.
(Protocol changes)
Merck Sharp & Dohme Corp.
Information provided by:
Hom, Milton M., OD, FAAO Identifier:
First received: June 19, 2007
Last updated: October 5, 2010
Last verified: October 2010

June 19, 2007
October 5, 2010
July 2007
Not Provided
Contact lens objective and subjective clinical performance testing [ Time Frame: up to 3 months ]
Same as current
Complete list of historical versions of study NCT00489398 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Comparison of CL Wear Between Two Allergy Drops
Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride
Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
Contact lens patients will instill allergy drops and subjective and objective tests will be performed
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Treatment
Allergic Conjunctivitis
Drug: epinastine HCL and olopatadine HCL
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
December 2008
Not Provided

Inclusion Criteria:

  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
Not Provided
Not Provided
Milton M. Hom, OD, FAAO.
Hom, Milton M., OD, FAAO
Merck Sharp & Dohme Corp.
Study Director: Milton M Hom, OD FAAO Private Practice
Hom, Milton M., OD, FAAO
October 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP